The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Severskaya N.V.

Hertsen Federal Medical Research Centre, Obninsk, Russia

Semin D.Yu.

Hertsen Federal Medical Research Centre, Obninsk, Russia

Ilyin A.A.

Hertsen Federal Medical Research Centre, Obninsk, Russia

Ryzhenkova M.I.

Hertsen Federal Medical Research Centre, Obninsk, Russia

Chebotareva I.V.

Hertsen Federal Medical Research Centre, Obninsk, Russia

Difficulties of differential diagnostics of primary hyperparathyroidism and sarcoidosis of cervical lymph nodes

Authors:

Severskaya N.V., Semin D.Yu., Ilyin A.A., Ryzhenkova M.I., Chebotareva I.V.

More about the authors

Journal: Problems of Endocrinology. 2015;61(1): 57‑60

Read: 2652 times


To cite this article:

Severskaya NV, Semin DYu, Ilyin AA, Ryzhenkova MI, Chebotareva IV. Difficulties of differential diagnostics of primary hyperparathyroidism and sarcoidosis of cervical lymph nodes. Problems of Endocrinology. 2015;61(1):57‑60. (In Russ.)
https://doi.org/10.14341/probl201561157-60

Recommended articles:
Economic issues of medi­cal care for hype­rparathyroidism. Part 1. Primary hype­rparathyroidism. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):51-61
Broncho-obstructive diso­rders in sarcoidosis: in search of causes. Journal of Respiratory Medi­cine. 2025;(2):60-65
Anatomical and clinical substantiation of the opti­mal technique of mini­mally inva­sive para­thyroidectomy. Russian Journal of Operative Surgery and Clinical Anatomy. 2025;(2):22-29

References:

  1. Kanaji N. Paraneoplastic syndromes associated with lung cancer Nobuhiro Kanaji, Naoki Watanabe, Nobuyuki Kita, Shuji Bandoh, Akira Tadokoro, Tomoya Ishii, Hiroaki Dobashi, Takuya Matsunaga. World Journal of Clinical Oncology. 2014;5(3):197. doi: 10.5306/wjco.v5.i3.197.
  2. Pelosof LC, Gerber DE. Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment. Mayo Clinic Proceedings. 2010;85(9):838-854. doi: 10.4065/mcp.2010.0099.
  3. Krikorian A, Shah S, Wasman J. Parathyroid Hormone-Related Protein: An Unusual Mechanism for Hypercalcemia in Sarcoidosis. Endocrine Practice. 2011;17(4):e84-e86. doi: 10.4158/ep11060.cr.
  4. Pollak MR, Brown EM, Chou Y-HW, et al. Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 1993;75(7):1297-1303. doi: 10.1016/0092-8674(93)90617-y.
  5. Patel A, Adeseun G, Goldfarb S. Calcium-Alkali Syndrome in the Modern Era. Nutrients. 2013;5(12):4880-4893. doi: 10.3390/nu5124880.
  6. Rao DA, Dellaripa PF. Extrapulmonary Manifestations of Sarcoidosis. Rheumatic Disease Clinics of North America. 2013;39(2):277-297. doi: 10.1016/j.rdc.2013.02.007.
  7. Sharma OP. Vitamin D, Calcium, and Sarcoidosis. CHEST Journal. 1996;109(2):535. doi: 10.1378/chest.109.2.535.
  8. Adams JS, Singer FR, Gacad MA, et al. Isolation and Structural Identification of 1,25- Dihydroxyvitamin D3Produced by Cultured Alveolar Macrophages in Sarcoidosis*. The Journal of Clinical Endocrinology & Metabolism. 1985;60(5):960-966. doi: 10.1210/jcem-60-5-960.
  9. Adams JS. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am. 1989;18(3):765-778.
  10. Falk S, Kratzsch J, Paschke R, Koch CA. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Med Sci Monit. 2007;13(11):CS133-136.
  11. Newman LS, Rose CS, Bresnitz EA, et al. A Case Control Etiologic Study of Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 2004;170(12):1324-1330. doi: 10.1164/rccm.200402-249OC.
  12. Baughman RP, Teirstein AS, Judson MA, et al. Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 2001;164(10):1885-1889. doi: 10.1164/ajrccm.164.10.2104046.
  13. Harrell GT, Fisher S. Blood Chemical Changes in Boeck’s Sarcoid with Particular Reference to Protein, Calcium and Phosphatase Values. Journal of Clinical Investigation. 1939;18(6):687-693. doi: 10.1172/jci101084.
  14. Joglekar SP, Hudson RL, Logasundaram R, Pereira JH. ‘Surgical cure’ for non-parathyroid hypercalcemia. World Journal of Surgical Oncology. 2009;7(1):23. doi: 10.1186/1477-7819-7-23.
  15. Ackermann D. Die Hyperkalzämie im Verlauf der Sarkoidose – Fallbeispiel, Prävalenz, Pathophysiologie und Therapiemöglichkeiten. Therapeutische Umschau. 2007;64(5):281-286. doi: 10.1024/0040-5930.64.5.281.
  16. Kavathia D, Buckley JD, Rao D, et al. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respiratory Medicine. 2010;104(4):564-570. doi: 10.1016/j.rmed.2009.12.004.
  17. Zeimer HJ, Greenaway TM, Slavin J, et al. Parathyroid hormone related protein in sarcoidosis. Am J Pathol. 1998;152:17–21.
  18. Lim V, Clarke BL. Coexisting Primary Hyperparathyroidism and Sarcoidosis Cause Increased Angiotensin-Converting Enzyme and Decreased Parathyroid Hormone and Phosphate Levels. The Journal of Clinical Endocrinology & Metabolism. 2013;98(5):1939-1945. doi: 10.1210/jc.2012-4197.
  19. Cushard WG, Simon AB, Canterbury JM, Reiss E. Parathyroid Function in Sarcoidosis. New England Journal of Medicine. 1972;286(8):395-398. doi: 10.1056/nejm197202242860803.
  20. Boi F, Lombardo C, Cocco MC, et al. Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA-PTH assay. European Journal of Endocrinology. 2012;168(1):49-58. doi: 10.1530/eje-12-0742.
  21. Gommans GMM, van der Zant FM, van Dongen A, et al. 99MTechnetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography. European Journal of Surgical Oncology (EJSO). 2007;33(1):23-27. doi: 10.1016/j.ejso.2006.10.025.
  22. Oleynik NA, Rumyantsev PO, Il’in AA, et al. Primenenie tekhnetrila (MIBI) v diagnostike opukholey shchitovidnoy zhelezy i metastazov papillyarnogo raka shchitovidnoy zhelezy. Medical Radiology and Radiation Safety. 1999;44(1):35-43.
  23. Klieger P, O’Mara R. A Case of Active Sarcoid Mimicking a Mediastinal Parathyroid Adenoma on Tc-99m Sestamibi Imaging. Clinical Nuclear Medicine. 1998;23(8):534-535. doi: 10.1097/00003072-199808000-00011.
  24. Calo, Pisano G, Tatti A, et al. Cervical Lymph Node Sarcoidosis Mimicking a Parathyroid Adenoma: A Clinical Case. Clinical Medicine Insights: Case Reports. 2013:159. doi: 10.4137/CCRep.S13026.
  25. Nabriski D, Bendahan J, Shapiro MS, et al. Sarcoidosis masquerading as a parathyroid adenoma. Head & Neck. 1992;14(5):384-386. doi: 10.1002/hed.2880140508.
  26. FröBerg AC, De Herder WW, Bonjer HJ, et al. Tc-99m Sestamibi Before and During Treatment in a Patient With Sarcoidosis and Persistent Hyperparathyroidism. Clinical Nuclear Medicine. 2000;25(5):351-353. doi: 10.1097/00003072-200005000-00006.
  27. Dent CE. Cortisone Test for Hyperparathyroidism. Bmj. 1956;1(4960):230-230. doi: 10.1136/bmj.1.4960.230-a.
  28. Gwinup G. Cortisone Responsive Hypercalcemia in Proved Hyperparathyroidism. Annals of Internal Medicine. 1961;55(6):1001. doi: 10.7326/0003-4819-55-6-1001.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.